These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Immunocytochemical study at the ultrastructural level of neurofibrillary degeneration in Alzheimer's disease]. Defossez A, el Hachimi K, Beauvillain JC, Perre J, Delacourte A, Foncin JF. C R Acad Sci III; 1987; 304(9):217-22. PubMed ID: 3102001 [Abstract] [Full Text] [Related]
45. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Mann DM, Yates PO, Marcyniuk B. Neuropathol Appl Neurobiol; 1984; 10(3):185-207. PubMed ID: 6234474 [Abstract] [Full Text] [Related]
46. [Cytological structure of various subcortical and brain stem nuclei of human brain in the normal state and in Alzheimer's disease]. Amunts VV. Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):116-9. PubMed ID: 2609818 [Abstract] [Full Text] [Related]
50. Thalamic nuclei in Alzheimer disease: evidence against the cholinergic hypothesis of plaque formation. Masliah E, Terry R, Buzsáki G. Brain Res; 1989 Jul 31; 493(2):240-6. PubMed ID: 2765898 [Abstract] [Full Text] [Related]
51. Cockayne's syndrome: report of two autopsy cases associated with neurofibrillary tangles. Takada K, Becker LE. Clin Neuropathol; 1986 Jul 31; 5(2):64-8. PubMed ID: 3708954 [Abstract] [Full Text] [Related]
52. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Bondareff W, Mountjoy CQ, Roth M, Hauser DL. Neurobiol Aging; 1989 Jul 31; 10(6):709-15. PubMed ID: 2628782 [Abstract] [Full Text] [Related]
53. A review of neuropathological and neurochemical correlates of Alzheimer's disease. Perry EK, Perry RH. Dan Med Bull; 1985 Feb 31; 32 Suppl 1():27-34. PubMed ID: 2859148 [No Abstract] [Full Text] [Related]
54. Cytometrical and immunocytochemical investigation of brain nuclei in dementia. Dom R, Lammens M, Saedeleer JD, Hauman H. Prog Clin Biol Res; 1989 Feb 31; 317():375-81. PubMed ID: 2602424 [Abstract] [Full Text] [Related]
55. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Iraizoz I, de Lacalle S, Gonzalo LM. Neuroscience; 1991 Feb 31; 41(1):33-40. PubMed ID: 2057064 [Abstract] [Full Text] [Related]
56. Regional brain trace-element studies in Alzheimer's disease. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE. Neurotoxicology; 1988 Feb 31; 9(1):1-7. PubMed ID: 3393299 [Abstract] [Full Text] [Related]
57. Meningio-angiomatosis: a report of six cases with special reference to the occurrence of neurofibrillary tangles. Halper J, Scheithauer BW, Okazaki H, Laws ER. J Neuropathol Exp Neurol; 1986 Jul 31; 45(4):426-46. PubMed ID: 3088216 [Abstract] [Full Text] [Related]
58. Pathological evidence for neurotransmitter deficits in Down's syndrome of middle age. Mann DM, Yates PO, Marcyniuk B, Ravindra CR. J Ment Defic Res; 1985 Jun 31; 29 ( Pt 2)():125-35. PubMed ID: 2411933 [Abstract] [Full Text] [Related]
59. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Chen CP, Eastwood SL, Hope T, McDonald B, Francis PT, Esiri MM. Neuropathol Appl Neurobiol; 2000 Aug 31; 26(4):347-55. PubMed ID: 10931368 [Abstract] [Full Text] [Related]
60. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem. Kowall NW, Pendlebury WW, Kessler JB, Perl DP, Beal MF. Neuroscience; 1989 Aug 31; 29(2):329-37. PubMed ID: 2725861 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]